Aura Biosciences (AURA) EBIT Growth (1y) (2021 - 2026)
Aura Biosciences (AURA) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -20.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.08% |
| Dec 31, 2025 | 2.05% |
| Sep 30, 2025 | -20.12% |
| Jun 30, 2025 | -25.71% |
| Mar 31, 2025 | -30.13% |
| Dec 31, 2024 | -12.20% |
| Sep 30, 2024 | -13.39% |
| Jun 30, 2024 | -12.26% |
| Mar 31, 2024 | -14.76% |
| Dec 31, 2023 | -40.71% |
| Sep 30, 2023 | -27.61% |
| Jun 30, 2023 | -46.76% |
| Mar 31, 2023 | -51.78% |
| Dec 31, 2022 | -51.48% |
| Sep 30, 2022 | -80.49% |
| Jun 30, 2022 | -56.98% |
| Mar 31, 2022 | -116.15% |
| Dec 31, 2021 | -136.85% |
| Sep 30, 2021 | -144.97% |